Other key findings from the report include the following:
• The current annual medical cost associated with colorectal cancer is approximately $14 billion, the second highest following breast cancer, which has a current annual cost of $16.5 billion.
• There were approximately 13.8 million living cancer survivors in 2010.
• If the cancer incidence and survival rates remain the same, the number of cancer survivors in 2020 will increase to approximately 18.1 million.
Read the report about the cost of cancer.
Read other coverage about colorectal cancer:
– USPSTF Advises Against CRC Screening for Individuals Older Than 85
– Patients’ Ethnic and Gender Preference on Endoscopists Could Causes Barriers to CRC Screening
– Study Assesses Factors Affecting Rates of Colorectal Cancer Screening
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.